ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,664Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 623

$710K Total Retail Price of All Prescriptions

Rank: 15 out of 623

604 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 604 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

4% of this provider’s 604 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 11,811 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
AMLODIPINE BESYLATE 768 656 1 3
LISINOPRIL 668 522 2 1
FUROSEMIDE 546 472 3 5
SIMVASTATIN 546 476 3 2
METOPROLOL TARTRATE 461 348 5 9
METOPROLOL SUCCINATE 358 292 6 13
LEVOTHYROXINE SODIUM 352 272 7 4
LOSARTAN POTASSIUM 316 260 8 16
TRAMADOL HCL 311 242 9 15
OMEPRAZOLE 310 230 10 7
HYDROCHLOROTHIAZIDE 272 191 11 8
METFORMIN HCL 249 171 12 6
JANTOVEN 203 147 13 54
ATENOLOL 178 162 14 12
LOVASTATIN 174 164 15 25
PANTOPRAZOLE SODIUM 174 123 15 26
JANUVIA 173 149 17 87
CITALOPRAM HBR 170 145 18 21
PRAVASTATIN SODIUM 160 119 19 11
GABAPENTIN 155 130 20 18
RANITIDINE HCL 153 116 21 23
DONEPEZIL HCL 148 148 22 27
LANTUS 144 103 23 41
HYDRALAZINE HCL 142 117 24 70
NAPROXEN 133 106 25 89
LISINOPRIL-HYDROCHLOROTHIAZIDE 132 107 26 19
ATORVASTATIN CALCIUM 131 92 27 10
RISPERIDONE 131 125 27 49
GLIMEPIRIDE 127 111 29 38
FLUTICASONE PROPIONATE 126 90 30 29
KLOR-CON M20 122 113 31 62
MIRTAZAPINE 122 97 31 31
ALENDRONATE SODIUM 121 107 33 37
CLOPIDOGREL 121 99 33 34
SERTRALINE HCL 114 103 35 20
TAMSULOSIN HCL 111 91 36 35
TRAZODONE HCL 108 92 37 36
COLCRYS 108 88 37 175
CRESTOR 107 82 39 28
CARVEDILOL 104 78 40 32
NIFEDIPINE ER 104 92 40 90
FENTANYL 104 104 S2 40 76
ADVAIR DISKUS 94 76 43 39
ALLOPURINOL 93 88 44 44
LIDODERM 90 89 45 82
AMLODIPINE BESYLATE-BENAZEPRIL 89 89 46 92
DIOVAN 88 74 47 48
LYRICA 84 61 48 86
PLAVIX 77 63 49 46
NOVOLOG 77 65 49 75
LOSARTAN-HYDROCHLOROTHIAZIDE 72 69 51 59
BACLOFEN 71 34 52 115
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 53 53 78
SPIRONOLACTONE 66 53 54 101
DIGOXIN 66 65 54 63
VENTOLIN HFA 65 43 56 92
WARFARIN SODIUM 65 55 56 14
CLONIDINE HCL 65 31 56 55
OXYCODONE HCL 64 53 S2 59 30
INSULIN SYRINGE 63 38 60 80
ISOSORBIDE MONONITRATE ER 62 61 61 64
POTASSIUM CHLORIDE 62 57 61 24
HUMALOG 56 41 63 148
SPIRIVA 55 51 64 58
PREDNISONE 55 45 64 40
NIFEDICAL XL 54 42 66 274
LACTULOSE 54 50 66 67
LANSOPRAZOLE 53 47 68 147
IBUPROFEN 52 40 69 68
QUETIAPINE FUMARATE 52 34 69 51
ESCITALOPRAM OXALATE 52 33 69 60
CIPROFLOXACIN HCL 52 46 69 61
OXYBUTYNIN CHLORIDE 51 42 73 134
ABILIFY 50 38 74 166
PROAIR HFA 50 14 74 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.